Medicare Part D and Enhancing Patient Assistance Programs
Quorum assists client with new regulations that pertain to PAPs under the Medicare Part D drug benefit
Clinical Trial Reimbursement
Client received Category B status for an IDE, and Quorum points them to best practices for coverage.
Local Coverage Determination Policies Case Study
Comprehensive reimbursement strategy aimed at key decision makers results in favorable coverage for ophthalmic diagnostic device with large Medicare carriers.
Using Data to Assess Market Opportunities and Barriers for the Implementation of New Technology
A medical device company was concerned with the challenges that providers face in securing appropriate reimbursement through Medicare and private payers for a procedure involving one of their newest technologies. The company retained Quorum Consulting to evaluate reimbursement opportunities and barriers associated with the widespread adoption of their technology.
Wireless Device Manufacturer Gets Answers to Critical Marketplace Questions
Quorum analyzes historical Medicare claims data to evaluate market opportunities and third-party payer reimbursement.
Target Market Analysis Helps Biotech with Acquisition Confidence
Company needs comprehensive market intelligence to understand range of issues surrounding acquisition target in unfamiliar transplant market.
Pricing Strategy for Orphan Drug
Start up biotech needs to set a price for innovative orphan drug while leveraging potential for off label use.
Cost Effectiveness Tool in Dermatologic Agent
Quorum Consulting builds tool to identify cost effectiveness in novel dermatologic agent